Acetazolamide opens the muscular KCa2+, channel:: A novel mechanism of action that may explain the therapeutic effect of the drug in hypokalemic periodic paralysis Article

Tricarico, D, Barbieri, M, Camerino, DC. (2000). Acetazolamide opens the muscular KCa2+, channel:: A novel mechanism of action that may explain the therapeutic effect of the drug in hypokalemic periodic paralysis . ANNALS OF NEUROLOGY, 48(3), 304-312. 10.1002/1531-8249(200009)48:3<304::AID-ANA4>3.0.CO;2-A

cited authors

  • Tricarico, D; Barbieri, M; Camerino, DC

sustainable development goals

authors

publication date

  • September 1, 2000

published in

keywords

  • CALCIUM
  • Clinical Neurology
  • EPISODIC ATAXIA
  • INHIBITION
  • INSULIN
  • Life Sciences & Biomedicine
  • Neurosciences
  • Neurosciences & Neurology
  • POTASSIUM CHANNELS
  • RAT
  • SENSITIVE K+ CHANNELS
  • SKELETAL-MUSCLE FIBERS
  • Science & Technology

publisher

  • LIPPINCOTT WILLIAMS & WILKINS

start page

  • 304

end page

  • 312

volume

  • 48

issue

  • 3